부산대학교 도서관

Objective: The objective of the study was to investigate the prevalence, risk factors and clinical significance of prechoroidal cleft (PC) among neovascular age‐related macular degeneration (nAMD) patients in a Caucasian population. Design: A retrospective observational cohort study. Methods: A total of 140 patients with naive nAMD were treated with anti‐vascular endothelial growth factor (VEGF) injections and a follow‐up of ≥24 months. Optical coherence tomography (OCT) scans were graded for the presence of PC, central subfield foveal thickness (CSFT), maximal retinal thickness (MRT), pigment epithelial detachment (PED), presence of intraretinal fluid (IRF), subretinal fluid (SRF) and subretinal hyper‐reflective material (SHRM) at baseline, 3, 6, 12 and 24 months. Best corrected visual acuity (BCVA) and anti‐VEGF treatments were recorded. Results: Out of 140, 21 eyes (15%) developed PC. BCVA improved significantly from 0.68 ± 0.56 to 0.62 ± 0.59 logMAR after 24 months (p = 0.008). The change in BCVA was not related to the presence of cleft (p = 0.208). Multivariate analysis confirmed that higher baseline CSFT (p = 0.011, OR = 1.004, 95%, CI 1.001–1.007) and the presence of multi‐layered PED (p < 0.001, OR = 21.153, 95%, CI 5.591–80.026) were both predictive for development of PC. Eyes with PC received more injections than eyes without PC. Conclusion: Prechoroidal cleft was found in 15% of Caucasian nAMD patients treated with anti‐VEGF injections and was related to greater retinal and PED height, as well as presence of multi‐layered PED. Eyes with PC required more anti‐VEGF injections. The presence of PC correlates with disease activity, and intensive anti‐VEGF suppression can preserve vision. [ABSTRACT FROM AUTHOR]